Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

Last updated: September 4, 2024
Sponsor: CairnSurgical, Inc.
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Breast Cancer Locator (BCL) guided partial mastectomy

Wire Localized (WL) partial mastectomy

Clinical Study ID

NCT04397185
BCL IDE
  • Ages > 18
  • Female

Study Summary

This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer Locator (BCL) in subjects with non-palpable invasive breast cancer or ductal carcinoma in situ (DCIS). Subjects will be randomized to breast conserving surgery (BCS) utilizing either the BCL or wire localization (WL) to guide surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female gender

  • Age > 18 years

  • Histologic diagnosis of invasive breast cancer or DCIS

  • The surgeon determines that pre-operative tumor localization is required because thetumor cannot be definitively detected by palpation

  • The tumor is unifocal or multifocal with satellite lesions < or = 2 cm from primarytumor

  • The tumor enhances on prone breast MRI imaging

  • The tumor is ≥ 1 cm in diameter on prone breast MRI

  • Subject and surgeon agree to perform BCS

  • Subject voluntarily provides informed consent

Exclusion

Exclusion Criteria:

  • Absolute contraindication to MRI, including presence of implanted electrical device (e.g., pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in ornear eyes

  • Severe claustrophobia that precludes prone or supine MRI

  • Contraindication to use of gadolinium-based intravenous contrast, including life-threatening allergy

  • Compromised renal function including chronic, severe kidney disease (GFR < 30ml/min/1.73m2), or acute kidney injury

  • Pregnancy - In women of childbearing potential, a urine pregnancy test will beperformed

  • Subjects who have received or plan to receive neoadjuvant chemotherapy

  • Sternal notch to nipple distance of > 32 cm as measured in a sitting or standingposition

  • Measurement of widest circumference around breasts and arms > 135 cm for sites using 60cm bore scanners, and measurement of widest circumference around breasts and arms >145 cm for sites using 70 cm bore scanners

  • Subjects with known allergy to materials present in the device

  • Use of localization with devices other than a localization wire, includingintraoperative ultrasound guidance, radiofrequency emitting implants, magneticseeds, radioactive seeds, and tissue inspection devices (MarginProbe)

  • Subject would require > 2 localization wires, if randomized to standard of care

  • Subjects with multicentric tumors (additional tumors > 2 cm from primary)

  • Subject would require chest wall muscle nerve block as part of the operation

Study Design

Total Participants: 448
Treatment Group(s): 2
Primary Treatment: Breast Cancer Locator (BCL) guided partial mastectomy
Phase:
Study Start date:
December 23, 2020
Estimated Completion Date:
April 30, 2025

Study Description

The BCL System is intended to be used to guide a surgeon when performing partial mastectomy for breast cancer and to minimize positive margins. The purpose of this study is to provide evidence that the BCL is safe, effective, and non-inferior to the standard of care (WL) in the removal of non-palpable invasive breast cancer and DCIS.

Investigators in the intervention group will be provided with a three dimensional (3D) image of the cancer in the breast which allows them to visualize the closest distance from the tumor to the skin and the chest wall and quantifies those distances. Investigators will also use a BCL, which is a patient specific, plastic, bra-like form that is transiently placed on the breast prior to surgery and allows the Investigator to mark the projected edges of the tumor on the breast skin and to place bracketing wires inside the breast which define the center of the cancer and distances 1 cm from the tumor edges defined by pre-operative supine MRI.

Connect with a study center

  • Princess Margaret Cancer Centre

    Toronto, Ontario M5G 2M9
    Canada

    Site Not Available

  • Royal Free London NHS Trust

    London,
    United Kingdom

    Site Not Available

  • Manchester University NHS

    Manchester,
    United Kingdom

    Site Not Available

  • Arizona Center for Cancer Care

    Scottsdale, Arizona 85258
    United States

    Site Not Available

  • BASS Medical Group

    Walnut Creek, California 94598
    United States

    Site Not Available

  • Baptist MD Anderson Cancer Center

    Jacksonville, Florida 32207
    United States

    Site Not Available

  • Moffitt Cancer Center

    Tampa, Florida 33612
    United States

    Site Not Available

  • Tufts Medical Center

    Boston, Massachusetts 02111
    United States

    Site Not Available

  • Mass General/North Shore Center for Outpatient Care

    Danvers, Massachusetts 01923
    United States

    Site Not Available

  • Steward Medical Group

    Easton, Massachusetts 02356
    United States

    Site Not Available

  • Hennepin Healthcare

    Minneapolis, Minnesota 55415
    United States

    Site Not Available

  • Cheshire Medical Center

    Keene, New Hampshire 03431
    United States

    Site Not Available

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire 03766
    United States

    Site Not Available

  • Catholic Medical Center

    Manchester, New Hampshire 03102
    United States

    Active - Recruiting

  • St. Joseph Hospital

    Nashua, New Hampshire 03060
    United States

    Site Not Available

  • Summit Health

    Florham Park, New Jersey 07932
    United States

    Site Not Available

  • St. Peter's Hospital

    Albany, New York 12208
    United States

    Site Not Available

  • Kings County Hospital Center

    Brooklyn, New York 11207
    United States

    Site Not Available

  • Columbia Medical Center

    New York, New York 10032
    United States

    Site Not Available

  • Columbia University Irving Medical Center and New York-Presbyterian Hospital

    New York, New York 10032
    United States

    Site Not Available

  • Montefiore Nyack Hospital

    Nyack, New York 10960
    United States

    Site Not Available

  • The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio 43212
    United States

    Site Not Available

  • Women and Infants Hospital

    Providence, Rhode Island 02905
    United States

    Site Not Available

  • Kent Hospital

    Warwick, Rhode Island 02886
    United States

    Site Not Available

  • MD Anderson Cancer Center

    Houston, Texas 77030
    United States

    Site Not Available

  • Southwestern Vermont Medical Center

    Bennington, Vermont 05201
    United States

    Site Not Available

  • Rutland Regional Medical Center

    Rutland, Vermont 05701
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.